Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Breathlessness and fatigue most common in self reported long-COVID

Breathlessness and fatigue most common in self reported long-COVID

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines

Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

Time-varying transmission heterogeneity of two significant beta-coronavirus epidemics in Hong Kong

Time-varying transmission heterogeneity of two significant beta-coronavirus epidemics in Hong Kong

Exploring the oligomerizing behavior of SARS-CoV-2 accessory protein 7b

Exploring the oligomerizing behavior of SARS-CoV-2 accessory protein 7b

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.